A genome-wide association study for serum bilirubin levels and gene-environment interaction in a chinese population

Genetic Epidemiology

Volumn 37, Issue 3, 2013, Pages 293-300

  Dai, Xiayun ^a   Wu, Chen ^b   He, Yunfeng ^a   Gui, Lixuan ^a   Zhou, Li ^a,c   Guo, Huan ^a   Yuan, Jing ^a   Yang, Binyao ^a   Li, Jun ^a   Deng, Qifei ^a   Huang, Suli ^a   Guan, Lei ^a   Hu, Die ^a   Zhu, Jiang ^d   Min, Xinwen ^d   Lang, Mingjian ^d   Li, Dongfeng ^d   Yang, Handong ^d   Hu, Frank B ^e   Lin, Dongxin ^b   Wu, Tangchun ^a   He, M ^a   more..

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b CANCER HOSPITAL   (China)

^c CHONGQING MEDICAL UNIVERSITY   (China)

^d HUBEI UNIVERSITY OF MEDICINE   (China)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Ethnic differences; Gene smoking interaction; GWAS

Indexed keywords

BILIRUBIN; GLUCURONOSYLTRANSFERASE 1A1; MEMBRANE PROTEIN; PROTEIN SLCO1B3; UNCLASSIFIED DRUG;

AGE; ALCOHOL CONSUMPTION; ARTICLE; BILIRUBIN BLOOD LEVEL; BODY MASS; CHINESE; CONTROLLED STUDY; ETHNICITY; EUROPEAN AMERICAN; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOME ANALYSIS; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; MALE; NORMAL HUMAN; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

AGE FACTORS; ASIAN CONTINENTAL ANCESTRY GROUP; BILIRUBIN; BODY MASS INDEX; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE-ENVIRONMENT INTERACTION; GENOME-WIDE ASSOCIATION STUDY; GLUCURONOSYLTRANSFERASE; HUMANS; MALE; ORGANIC ANION TRANSPORTERS, SODIUM-INDEPENDENT; POLYMORPHISM, SINGLE NUCLEOTIDE; SMOKING;

EID: 84875679279     PISSN: 07410395     EISSN: 10982272     Source Type: Journal    
DOI: 10.1002/gepi.21711     Document Type: Article

References (39)

1. Bosma PJ, Chowdhury JR, Bakker C, Gantla S, de Boer A, Oostra BA, Lindhout D, Tytgat GN, Jansen PL, Oude Elferink RP and others. 1995. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med 333(18):1171-1175.
2. Briz O, Romero MR, Martinez-Becerra P, Macias RIR, Perez MJ, Jimenez F, Martin FGS, Marin JJG. 2006. OATP8/1B3-mediated cotransport of bile acids and glutathione: an export pathway for organic anions from hepatocytes? J Biol Chem 281(41):30326-30335.
3. Chang Y, Ryu S, Zhang Y, Son HJ, Kim JY, Cho J, Guallar E. 2012. A cohort study of serum bilirubin levels and incident nonalcoholic fatty liver disease in middle-aged Korean workers. PLoS ONE 7(5):e37241.
4. Chen G, Ramos E, Adeyemo A, Shriner D, Zhou J, Doumatey AP, Huang H, Erdos MR, Gerry NP, Herbert A and others. 2012. UGT1A1 is a major locus influencing bilirubin levels in African Americans. Eur J Hum Genet 20(4):463-468.
5. Djoussé L, Levy D, Cupples LA, Evans JC, D'Agostino RB, Ellison RC. 2001. Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study. Am J Cardiol 87(10):1196-1200; A1194-A1197.
6. Fischman D, Valluri A, Gorrepati VS, Murphy ME, Peters I, Cheriyath P. 2010. Bilirubin as a protective factor for rheumatoid arthritis: an NHANES study of 2003-2006 data. J Clin Med Res 2(6):256-260.
7. Frei B, Forte TM, Ames BN, Cross CE. 1991. Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma. Protective effects of ascorbic acid. Biochem J 277(Pt 1):133-138.
8. Gauderman W, Morrison J. 2006. QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies, http://hydra.usc.edu/gxe.
9. Hagenbuch B, Gui C. 2008. Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family. Xenobiotica 38(7-8):778-801.
10. Huang CS, Huang MJ, Lin MS, Yang SS, Teng HC, Tang KS. 2005. Genetic factors related to unconjugated hyperbilirubinemia amongst adults. Pharmacogenet Genomics 15(1):43-50.
11. Hunt SC, Kronenberg F, Eckfeldt JH, Hopkins PN, Myers RH, Heiss G. 2001. Association of plasma bilirubin with coronary heart disease and segregation of bilirubin as a major gene trait: the NHLBI family heart study. Atherosclerosis 154(3):747-754.
12. Hwang HJ, Kim SH. 2010. Inverse relationship between fasting direct bilirubin and metabolic syndrome in Korean adults. Clin Chim Acta 411(19-20):1496-1501.
13. Ieiri I, Suzuki H, Kimura M, Takane H, Nishizato Y, Irie S, Urae A, Kawabata K, Higuchi S, Otsubo K and others. 2004. Influence of common variants in the pharmacokinetic genes (OATP-C, UGT1A1, and MRP2) on serum bilirubin levels in healthy subjects. Hepatol Res 30(2):91-95.
14. Iyanagi T, Emi Y, Ikushiro S. 1998. Biochemical and molecular aspects of genetic disorders of bilirubin metabolism. Biochim Biophys Acta 1407(3):173-184.
15. Johnson AD, Handsaker RE, Pulit SL, Nizzari MM, O'Donnell CJ, de Bakker PI. 2008. SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 24(24):2938-2939.
16. Johnson AD, Kavousi M, Smith AV, Chen MH, Dehghan A, Aspelund T, Lin JP, van Duijn CM, Harris TB, Cupples LA and others. 2009. Genome-wide association meta-analysis for total serum bilirubin levels. Hum Mol Genet 18(14):2700-2710.
17. Kamisako T, Kobayashi Y, Takeuchi K, Ishihara T, Higuchi K, Tanaka Y, Gabazza EC, Adachi Y. 2000. Recent advances in bilirubin metabolism research: the molecular mechanism of hepatocyte bilirubin transport and its clinical relevance. J Gastroenterol 35(9):659-664.
18. Kang TW, Kim HJ, Ju H, Kim JH, Jeon YJ, Lee HC, Kim KK, Kim JW, Lee S, Kim JY and others. 2010. Genome-wide association of serum bilirubin levels in Korean population. Hum Mol Genet 19(18):3672-3678.
19. Kronenberg F, Coon H, Gutin A, Abkevich V, Samuels ME, Ballinger DG, Hopkins PN, Hunt SC. 2002. A genome scan for loci influencing antiatherogenic serum bilirubin levels. Eur J Hum Genet 10(9):539-546.
20. Letschert K, Keppler D, Konig J. 2004. Mutations in the SLCO1B3 gene affecting the substrate specificity of the hepatocellular uptake transporter OATP1B3 (OATP8). Pharmacogenetics 14(7):441-452.
21. Lu SC. 2009. Regulation of glutathione synthesis. Mol Aspects Med 30(1-2):42-59.
22. Melton PE, Haack K, Goring HH, Laston S, Umans JG, Lee ET, Fabsitz RR, Devereux RB, Best LG, Maccluer JW and others. 2011. Genetic influences on serum bilirubin in American Indians: the strong heart family study. Am J Hum Biol 23(1):118-125.
23. Nakagami T, Toyomura K, Kinoshita T, Morisawa S. 1993. A beneficial role of bile pigments as an endogenous tissue protector: Anti-complement effects of biliverdin and conjugated bilirubin. Biochim Biophys Acta 1158(2):189-193.
24. Novotný L, Vítek L. 2003. Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies. Exp Biol Med 228(5):568-571.
25. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. 2006. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38(8):904-909.
26. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, Maller J, Sklar P, de Bakker PIW, Daly MJ and others. 2007. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81(3):559-575.
27. Rodrigues C, Costa E, Vieira E, De Carvalho J, Santos R, Rocha-Pereira P, Santos-Silva A, Bronze-da-Rocha E. 2012. Bilirubin dependence on UGT1A1 polymorphisms, hemoglobin, fasting time, and body mass index. Am J Med Sci 343(2):114-118.
28. Rosenthal P, Pincus M, Fink D. 1984. Sex- and age-related differences in bilirubin concentrations in serum. Clin Chem 30(8):1380-1382.
29. Sanna S, Busonero F, Maschio A, McArdle PF, Usala G, Dei M, Lai S, Mulas A, Piras MG, Perseu L and others. 2009. Common variants in the SLCO1B3 locus are associated with bilirubin levels and unconjugated hyperbilirubinemia. Hum Mol Genet 18(14):2711-2718.
30. Schwertner HA. 1998. Association of smoking and low serum bilirubin antioxidant concentrations. Atherosclerosis 136(2):383-387.
31. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. 1987. Bilirubin is an antioxidant of possible physiological importance. Science 235(4792):1043-1046.
32. Torgerson JS, Lindroos AK, Sjostrom CD, Olsson R, Lissner L, Sjostrom L. 1997. Are elevated aminotransferases and decreased bilirubin additional characteristics of the metabolic syndrome? Obes Res 5(2):105-114.
33. Van Hoydonck PG, Temme EH, Schouten EG. 2001. Serum bilirubin concentration in a Belgian population: the association with smoking status and type of cigarettes. Int J Epidemiol 30(6):1465-1472.
34. Vítek L. 2012. The role of bilirubin in diabetes, metabolic syndrome, and cardiovascular diseases. Front Pharmacol 3:55, doi: 10.3389/fphar.2012.00055.
35. Wang F, Zhu J, Yao P, Li X, He M, Liu Y, Yuan J, Chen W, Zhou L, Min X and others. 2012. Cohort profile: the Dongfeng-Tongji cohort study of retired workers. Int J Epidemiol. doi:10.1093/ije/dys053.
36. Wang X, Chowdhury JR, Chowdhury NR. 2006. Bilirubin metabolism: applied physiology. Curr Paediatr 16(1):70-74.
37. Wu TW, Fung KP, Wu J, Yang CC, Weisel RD. 1996. Antioxidation of human low-density lipoprotein by unconjugated and conjugated bilirubins. Biochem Pharmacol 51(6):859-862.
38. Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF. 2007. Systemic effects of smoking. Chest 131(5):1557-1566.
39. Zucker SD, Horn PS, Sherman KE. 2004. Serum bilirubin levels in the U.S. population: gender effect and inverse correlation with colorectal cancer. Hepatology 40(4):827-835.